Melodiol Global Health (COPHD)
OTHER OTC:COPHD
Holding COPHD?
Track your performance easily

Melodiol Global Health (COPHD) Stock Price & Analysis

24 Followers

COPHD Stock Chart & Stats


COPHD FAQ

What was Melodiol Global Health’s price range in the past 12 months?
Currently, no data Available
What is Melodiol Global Health’s market cap?
Currently, no data Available
When is Melodiol Global Health’s upcoming earnings report date?
Melodiol Global Health’s upcoming earnings report date is Aug 28, 2024 which is 77 days ago.
    How were Melodiol Global Health’s earnings last quarter?
    Melodiol Global Health released its earnings results on Feb 29, 2024. The company reported -$2.334 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.334.
      Is Melodiol Global Health overvalued?
      According to Wall Street analysts Melodiol Global Health’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Melodiol Global Health pay dividends?
        Melodiol Global Health does not currently pay dividends.
        What is Melodiol Global Health’s EPS estimate?
        Melodiol Global Health’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Melodiol Global Health have?
        Currently, no data Available
        What happened to Melodiol Global Health’s price movement after its last earnings report?
        Melodiol Global Health reported an EPS of -$2.334 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -61.034%.
          Which hedge fund is a major shareholder of Melodiol Global Health?
          Currently, no hedge funds are holding shares in COPHD
          ---

          Melodiol Global Health Stock Smart Score

          10
          Unlock Smart Score
          1
          2
          3
          4
          5
          6
          7
          8
          9
          10

          Fundamentals

          Return on Equity
          -385.89%
          Trailing 12-Months
          Asset Growth
          -49.55%
          Trailing 12-Months

          Company Description

          Melodiol Global Health

          Creso Pharma Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its product portfolio includes Creso Animal Health products, Nutraceutical products, Topical products, Therapeutics products, and Lifestyle products. The company has operations in Switzerland, Canada, Colombia, Israel and Australia. The company derives prime revenue from the Europe and Middle East regions.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Cocrystal Pharma
          Crispr Therapeutics AG
          Agenus
          Merck & Company
          Popular Stocks
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis